Your browser doesn't support javascript.
loading
Electronic Cigarette Exposure Increases the Severity of Influenza a Virus Infection via TRAIL Dysregulation in Human Precision-Cut Lung Slices.
Agraval, Hina; Crue, Taylor; Schaunaman, Niccolette; Numata, Mari; Day, Brian J; Chu, Hong Wei.
Afiliação
  • Agraval H; Department of Medicine, National Jewish Health, 1400 Jackson Street, Denver, CO 80206, USA.
  • Crue T; School of Medicine, University of Colorado, 12700 E 19th Ave, Aurora, CO 80045, USA.
  • Schaunaman N; Department of Medicine, National Jewish Health, 1400 Jackson Street, Denver, CO 80206, USA.
  • Numata M; Department of Medicine, National Jewish Health, 1400 Jackson Street, Denver, CO 80206, USA.
  • Day BJ; Department of Medicine, National Jewish Health, 1400 Jackson Street, Denver, CO 80206, USA.
  • Chu HW; Department of Medicine, National Jewish Health, 1400 Jackson Street, Denver, CO 80206, USA.
Int J Mol Sci ; 24(5)2023 Feb 21.
Article em En | MEDLINE | ID: mdl-36901724
ABSTRACT
The use of electronic nicotine dispensing systems (ENDS), also known as electronic cigarettes (ECs), is common among adolescents and young adults with limited knowledge about the detrimental effects on lung health such as respiratory viral infections and underlying mechanisms. Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), a protein of the TNF family involved in cell apoptosis, is upregulated in COPD patients and during influenza A virus (IAV) infections, but its role in viral infection during EC exposures remains unclear. This study was aimed to investigate the effect of ECs on viral infection and TRAIL release in a human lung precision-cut lung slices (PCLS) model, and the role of TRAIL in regulating IAV infection. PCLS prepared from lungs of nonsmoker healthy human donors were exposed to EC juice (E-juice) and IAV for up to 3 days during which viral load, TRAIL, lactate dehydrogenase (LDH), and TNF-α in the tissue and supernatants were determined. TRAIL neutralizing antibody and recombinant TRAIL were utilized to determine the contribution of TRAIL to viral infection during EC exposures. E-juice increased viral load, TRAIL, TNF-α release and cytotoxicity in IAV-infected PCLS. TRAIL neutralizing antibody increased tissue viral load but reduced viral release into supernatants. Conversely, recombinant TRAIL decreased tissue viral load but increased viral release into supernatants. Further, recombinant TRAIL enhanced the expression of interferon-ß and interferon-λ induced by E-juice exposure in IAV-infected PCLS. Our results suggest that EC exposure in human distal lungs amplifies viral infection and TRAIL release, and that TRAIL may serve as a mechanism to regulate viral infection. Appropriate levels of TRAIL may be important to control IAV infection in EC users.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus da Influenza A / Influenza Humana / Sistemas Eletrônicos de Liberação de Nicotina Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus da Influenza A / Influenza Humana / Sistemas Eletrônicos de Liberação de Nicotina Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article